ROCKWELL MEDICAL, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
ROCKWELL MEDICAL, INC. (RMTI) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $2.06 per share for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2021-03-31
- ROCKWELL MEDICAL, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2019-03-31 was $4.93.
- ROCKWELL MEDICAL, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2019 was $4.93, a 59.55% increase from fiscal 2018.
- ROCKWELL MEDICAL, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2018 was $3.09, a 28.97% decline from fiscal 2017.
- ROCKWELL MEDICAL, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2017 was $4.35, a 40.32% increase from fiscal 2016.
- ROCKWELL MEDICAL, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2016 was $3.10, a 26.71% decline from fiscal 2015.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 1 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|---|---|
| 2020-06-30 | $2.06 10-Q · filed 2020-08-10 | |||||
| 2019-12-31 | $4.93 10-K · filed 2021-03-31 | |||||
| 2019-09-30 | $4.93 10-Q · filed 2019-11-12 | |||||
| 2019-06-30 | $4.93 10-Q · filed 2019-08-09 | |||||
| 2019-04-30 | $5.25 10-Q · filed 2019-11-12 | |||||
| 2019-03-31 | $4.93 10-Q · filed 2019-05-10 | |||||
| 2018-12-31 | $3.09 10-K · filed 2020-03-17 | |||||
| 2018-09-19 | $3.09 10-Q · filed 2018-11-09 | |||||
| 2017-12-31 | $4.35 10-K · filed 2018-03-15 | |||||
| 2016-12-31 | $3.10 10-K · filed 2018-03-15 | |||||
| 2015-12-31 | $4.23 10-K · filed 2018-03-15 | |||||
| 2014-12-31 | $4.17 10-K · filed 2017-03-15 | |||||
| 2013-12-31 | $1.60 10-K · filed 2016-02-29 | |||||
| 2012-12-31 | $0.61 10-K · filed 2015-03-03 | |||||
| 2011-12-31 | $1.81 10-K · filed 2014-03-07 | |||||
| 2010-12-31 | $1.16 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |